StockData
Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. (MD) stock

MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/305% above fair value
$31.89+0.59 (+1.88%)

Close on Nov 16, 2026Market cap $2.49BP/E 17.3Yield –

Pediatrix Medical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pediatrix Medical's operating cash flow for the twelve months ending Sep 30, 2026 was $226.89M, down 21.8% year over year. For fiscal 2025 it was $271.09M, up 31.2% from the year before. Over ten years it grew -3.0% a year on average. The highest annual figure on record is $511.38M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$271.09M+31.2%
FY2024Dec 31, 2024$206.57M+50.4%
FY2023Dec 31, 2023$137.33M-17.7%
FY2022Dec 31, 2022$166.94M+117.5%
FY2021Dec 31, 2021$76.74M-62.5%
FY2020Dec 31, 2020$204.62M-42.8%
FY2019Dec 31, 2019$357.71M+14.0%
FY2018Dec 31, 2018$313.71M-38.7%
FY2017Dec 31, 2017$511.38M+15.2%
FY2016Dec 31, 2016$443.78M+20.4%
FY2015Dec 31, 2015$368.70M-12.8%
FY2014Dec 31, 2014$422.64M+4.3%
FY2013Dec 31, 2013$405.40M+24.8%
FY2012Dec 31, 2012$324.91M+20.0%
FY2011Dec 31, 2011$270.67M+12.5%
FY2010Dec 31, 2010$240.56M-0.3%
FY2009Dec 31, 2009$241.37M+33.1%
FY2008Dec 31, 2008$181.39M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$117.31M-14.6%
Q2 FY2026Jun 30, 2026$125.32M-8.6%
Q1 FY2026Mar 31, 2026-$129.85M–
Q4 FY2025Dec 31, 2025$114.10M-14.2%
Q3 FY2025Sep 30, 2025$137.29M+49.5%
Q2 FY2025Jun 30, 2025$137.17M+28.3%
Q1 FY2025Mar 31, 2025-$117.46M–
Q4 FY2024Dec 31, 2024$133.01M+92.1%
Q3 FY2024Sep 30, 2024$91.84M+14.9%
Q2 FY2024Jun 30, 2024$106.95M+20.1%
Q1 FY2024Mar 31, 2024-$125.23M–
Q4 FY2023Dec 31, 2023$69.25M-29.8%
Q3 FY2023Sep 30, 2023$79.94M-4.1%
Q2 FY2023Jun 30, 2023$89.05M+8.1%
Q1 FY2023Mar 31, 2023-$100.92M–
Q4 FY2022Dec 31, 2022$98.69M+123.1%
Q3 FY2022Sep 30, 2022$83.33M+36.4%
Q2 FY2022Jun 30, 2022$82.41M+53.8%
Q1 FY2022Mar 31, 2022-$97.48M–
Q4 FY2021Dec 31, 2021$44.24M–
Q3 FY2021Sep 30, 2021$61.10M-64.0%
Q2 FY2021Jun 30, 2021$53.59M-71.6%
Q1 FY2021Mar 31, 2021-$82.19M–
Q4 FY2020Dec 31, 2020-$11.87M-108.8%
Q3 FY2020Sep 30, 2020$169.94M+6.7%
Q2 FY2020Jun 30, 2020$188.44M+57.0%
Q1 FY2020Mar 31, 2020-$141.88M–
Q4 FY2019Dec 31, 2019$135.30M-10.6%
Q3 FY2019Sep 30, 2019$159.20M+13.1%
Q2 FY2019Jun 30, 2019$120.03M-11.2%
Q1 FY2019Mar 31, 2019-$56.82M–
Q4 FY2018Dec 31, 2018$151.38M-22.6%
Q3 FY2018Sep 30, 2018$140.73M-29.6%
Q2 FY2018Jun 30, 2018$135.24M-1.7%
Q1 FY2018Mar 31, 2018-$113.63M–
Q4 FY2017Dec 31, 2017$195.64M+49.4%
Q3 FY2017Sep 30, 2017$199.93M–
Q2 FY2017Jun 30, 2017$137.58M–
Q1 FY2017Mar 31, 2017-$21.76M–
Q4 FY2016Dec 31, 2016$130.95M–

More Pediatrix Medical figures

See a number that looks wrong?